• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工瓣膜心内膜炎

Prosthetic valve endocarditis.

作者信息

Braimbridge M V, Eykyn S J

机构信息

Department of Cardiothoracic Surgery, St Thomas' Hospital, London, UK.

出版信息

J Antimicrob Chemother. 1987 Sep;20 Suppl A:173-80. doi: 10.1093/jac/20.suppl_a.173.

DOI:10.1093/jac/20.suppl_a.173
PMID:3316160
Abstract

About 2% of patients with a prosthetic valve will develop endocarditis. This may occur within a few weeks of the valve replacement operation (early) or many months or years later (late). The infecting organisms, pathogenicity and prognosis differ in the two groups. The incidence of early prosthetic valve endocarditis (PVE) is under 1%; the predominant organisms are staphylococci that are acquired in the operating theatre or in the intensive therapy unit. Early PVE usually follows wound sepsis that may initially appear trivial. The mortality rate is around 70%, but such infections should be preventable by stringent antisepsis, good surgical technique and (perhaps) perioperative antistaphylococcal antibiotics. The incidence of late PVE is about 1% per annum. The infecting organisms are similar to those causing native valve endocarditis, predominantly streptococci. The commonest source of these organisms is the mouth and regular dental care and appropriate prophylactic antibiotics should help to prevent infection. The mortality rate of late PVE is around 10%. Failure of medical treatment in PVE is an indication for surgery to remove the infected valve(s) and this should not be delayed. The optimum length of treatment for PVE is unknown but it is seldom necessary to give antibiotics for more than 6 weeks except in Coxiella burnetii infection.

摘要

人工瓣膜置换术后约2%的患者会发生心内膜炎。这可能在瓣膜置换手术后几周内(早期)发生,也可能在数月或数年之后(晚期)发生。两组患者的感染病原体、致病性及预后有所不同。早期人工瓣膜心内膜炎(PVE)的发生率低于1%;主要病原体是在手术室或重症监护病房感染的葡萄球菌。早期PVE通常继发于起初看似轻微的伤口脓毒症。死亡率约为70%,但通过严格的防腐措施、良好的手术技术以及(或许)围手术期使用抗葡萄球菌抗生素,此类感染应可预防。晚期PVE的发生率约为每年1%。感染病原体与引起自身瓣膜心内膜炎的病原体相似,主要是链球菌。这些病原体最常见的来源是口腔,定期的牙齿护理及适当的预防性抗生素有助于预防感染。晚期PVE的死亡率约为10%。PVE内科治疗无效是手术切除感染瓣膜的指征,不应延误。PVE的最佳治疗时长尚不清楚,但除了伯氏考克斯体感染外,很少需要使用抗生素超过6周。

相似文献

1
Prosthetic valve endocarditis.人工瓣膜心内膜炎
J Antimicrob Chemother. 1987 Sep;20 Suppl A:173-80. doi: 10.1093/jac/20.suppl_a.173.
2
Infections of prosthetic heart valves and cardiac pacemakers.人工心脏瓣膜和心脏起搏器感染。
Infect Dis Clin North Am. 1989 Jun;3(2):221-45.
3
Aortic valve endocarditis. Determinants of early survival and late morbidity.主动脉瓣心内膜炎。早期生存及晚期发病的决定因素。
Circulation. 1994 Nov;90(5 Pt 2):II175-82.
4
Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review.早期人工瓣膜心内膜炎定义的再探讨:前瞻性研究和文献回顾。
Int J Infect Dis. 2018 Feb;67:3-6. doi: 10.1016/j.ijid.2017.09.004. Epub 2017 Sep 19.
5
[Treatment outcome of prosthetic valve endocarditis].[人工瓣膜心内膜炎的治疗结果]
Przegl Lek. 2003;60(9):549-52.
6
[Infective endocarditis in valve prostheses].[人工瓣膜感染性心内膜炎]
Cardiologia. 1991 Dec;36(12 Suppl 1):125-36.
7
Contemporary clinical profile and outcome of prosthetic valve endocarditis.人工瓣膜心内膜炎的当代临床特征与预后
JAMA. 2007 Mar 28;297(12):1354-61. doi: 10.1001/jama.297.12.1354.
8
[Clinical evaluations of surgical treatment of infective endocarditis].[感染性心内膜炎外科治疗的临床评估]
Nihon Kyobu Geka Gakkai Zasshi. 1989 Apr;37(4):600-5.
9
Comparison between early and late prosthetic valve endocarditis: clinical characteristics and outcomes.早期与晚期人工瓣膜心内膜炎的比较:临床特征与结局
J Heart Valve Dis. 2013 Jul;22(4):567-74.
10
Prosthetic valve endocarditis.人工瓣膜心内膜炎
J Thorac Cardiovasc Surg. 1980 Jul;80(1):31-7.

引用本文的文献

1
Prosthetic Aortic Valve Endocarditis Caused by Burkholderia cepacia complex: A Case Report.洋葱伯克霍尔德菌复合体引起的人工主动脉瓣心内膜炎:一例报告
Cureus. 2025 Aug 11;17(8):e89793. doi: 10.7759/cureus.89793. eCollection 2025 Aug.
2
Recognition, management and prophylaxis of endocarditis.心内膜炎的识别、管理与预防。
Drugs. 1997 Nov;54(5):730-44. doi: 10.2165/00003495-199754050-00005.